Number of the records: 1
Alboserpin, a Factor Xa Inhibitor from the Mosquito Vector of Yellow Fever, Binds Heparin and Membrane Phospholipids and Exhibits Antithrombotic Activity
- 1.
SYSNO ASEP 0364839 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Alboserpin, a Factor Xa Inhibitor from the Mosquito Vector of Yellow Fever, Binds Heparin and Membrane Phospholipids and Exhibits Antithrombotic Activity Author(s) Calvo, E. (US)
Mizurini, D.M. (BR)
Sa-Nunes, A. (US)
Ribeiro, J.M.C. (US)
Andersen, J. F. (US)
Mans, B.J. (US)
Monteiro, R.Q. (BR)
Kotsyfakis, Michalis (BC-A) RID, ORCID
Francischetti, I.M.B. (US)Source Title Journal of Biological Chemistry. - : Elsevier - ISSN 0021-9258
Roč. 286, č. 32 (2011), 27998-28010Number of pages 13 s. Language eng - English Country US - United States Keywords serpin ; mosquito ; Aedes albopictus ; phospholipids ; Factor Xa ; heparin ; binding affinity ; coagulation ; thrombus ; bleeding Subject RIV GJ - Animal Vermins ; Diseases, Veterinary Medicine CEZ AV0Z60220518 - PAU-O, BC-A (2005-2011) UT WOS 000293557800018 DOI 10.1074/jbc.M111.247924 Annotation The function of a mosquito anticoagulant serpin named as Alboserpin is presented. The recombinant protein binds to phospholipids and it inhibits the activity of human coagulation factor Xa. Binding is highly specific and is not detectable for FX, catalytic site-blocked FXa, thrombin and 12 other enzymes. Alboserpin displays high-affinity binding to heparin, but no change in FXa inhibition was observed in the presence of the cofactor, implying that bridging mechanisms did not take place. Alboserpin displays a potent pharmacological activity since it prevents thrombus formation provoked by ferric chloride injury of the carotid artery and it increases bleeding in a dose-dependent manner. Workplace Biology Centre (since 2006) Contact Dana Hypšová, eje@eje.cz, Tel.: 387 775 214 Year of Publishing 2012
Number of the records: 1